These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36569871)

  • 61. A Novel Overall Survival Prediction Signature Based on Cancer Stem Cell-Related Genes in Osteosarcoma.
    Xiao B; Liu L; Chen Z; Li A; Xia Y; Wang P; Xiang C; Zeng Y; Li H
    Front Cell Dev Biol; 2021; 9():753414. PubMed ID: 34733853
    [No Abstract]   [Full Text] [Related]  

  • 62. Single-cell RNA datasets and bulk RNA datasets analysis demonstrated
    Tu J; Wang D; Zheng X; Liu B
    Front Immunol; 2023; 14():911368. PubMed ID: 36814925
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Identification of immune-related genes as prognostic factors in bladder cancer.
    Zhu J; Wang H; Ma T; He Y; Shen M; Song W; Wang JJ; Shi JP; Wu MY; Liu C; Wang WJ; Huang YQ
    Sci Rep; 2020 Nov; 10(1):19695. PubMed ID: 33184436
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comprehensive
    Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
    Front Immunol; 2022; 13():931906. PubMed ID: 35958598
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Unfolded Protein Response-Related Signature Associates With the Immune Microenvironment and Prognostic Prediction in Osteosarcoma.
    Zhang Z; Liu X; Cheng D; Dang J; Mi Z; Shi Y; Wang L; Fan H
    Front Genet; 2022; 13():911346. PubMed ID: 35754801
    [No Abstract]   [Full Text] [Related]  

  • 66. Construction and validation of immune-related LncRNAs classifier to predict prognosis and immunotherapy response in laryngeal squamous cell carcinoma.
    Wang X; Pan Y; Ou Y; Duan T; Zou Y; Zhou X
    World J Surg Oncol; 2022 May; 20(1):164. PubMed ID: 35606755
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Development of a Machine Learning-Based Autophagy-Related lncRNA Signature to Improve Prognosis Prediction in Osteosarcoma Patients.
    Zhang GZ; Wu ZL; Li CY; Ren EH; Yuan WH; Deng YJ; Xie QQ
    Front Mol Biosci; 2021; 8():615084. PubMed ID: 34095215
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A Novel Model of Tumor-Infiltrating B Lymphocyte Specific RNA-Binding Protein-Related Genes With Potential Prognostic Value and Therapeutic Targets in Multiple Myeloma.
    Zhang J; He P; Wang X; Wei S; Ma L; Zhao J
    Front Genet; 2021; 12():778715. PubMed ID: 34976013
    [No Abstract]   [Full Text] [Related]  

  • 69. 12 Survival-related differentially expressed genes based on the TARGET-osteosarcoma database.
    Rothzerg E; Xu J; Wood D; Kõks S
    Exp Biol Med (Maywood); 2021 Oct; 246(19):2072-2081. PubMed ID: 33926256
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prognostic Signature of Osteosarcoma Based on 14 Autophagy-Related Genes.
    Qi W; Yan Q; Lv M; Song D; Wang X; Tian K
    Pathol Oncol Res; 2021; 27():1609782. PubMed ID: 34335109
    [No Abstract]   [Full Text] [Related]  

  • 71. Identification of key gene modules for human osteosarcoma by co-expression analysis.
    Zhang J; Lan Q; Lin J
    World J Surg Oncol; 2018 May; 16(1):89. PubMed ID: 29720180
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on T-cell marker genes to predict prognosis and therapeutic response in lung squamous cell carcinoma.
    Shi X; Dong A; Jia X; Zheng G; Wang N; Wang Y; Yang C; Lu J; Yang Y
    Front Immunol; 2022; 13():992990. PubMed ID: 36311764
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Establishment of immune prognostic signature and analysis of prospective molecular mechanisms in childhood osteosarcoma patients.
    Zhang Z; Liu C; Liang T; Yu C; Qin Z; Zhou X; Xue J; Zeng H; Lu Z; Xu G; Wang Z; Chen J; Jiang J; Zhan X
    Medicine (Baltimore); 2020 Nov; 99(46):e23251. PubMed ID: 33181717
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Integrated analysis of single-cell and bulk RNA sequencing data reveals prognostic characteristics of lysosome-dependent cell death-related genes in osteosarcoma.
    Wu Y; Yang J; Xu G; Chen X; Qu X
    BMC Genomics; 2024 Apr; 25(1):379. PubMed ID: 38632516
    [TBL] [Abstract][Full Text] [Related]  

  • 75. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.
    Wu Z; Zhang X; Chen D; Li Z; Wu X; Wang J; Deng Y
    Front Immunol; 2021; 12():806189. PubMed ID: 35095893
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Therapeutic potential of targeting
    Tang X; Luo L; Li Y; Wu H; Hu Q; Yue H; He X; Zou J; Min S
    Aging (Albany NY); 2020 Dec; 13(1):1212-1235. PubMed ID: 33291071
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Characterization of the Tumor Microenvironment in Osteosarcoma Identifies Prognostic- and Immunotherapy-Relevant Gene Signatures.
    Tan J; Feng X; Wu H; Yang B; Shi M; Xie C; Su Z; Li L; Luo M; Zuo Z; Zhu S; Yang J; Lin L
    J Immunol Res; 2022; 2022():6568278. PubMed ID: 36065454
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A five ferroptosis-related genes risk score for prognostic prediction of osteosarcoma.
    Ge Z; Song D
    Medicine (Baltimore); 2022 Dec; 101(50):e32083. PubMed ID: 36550843
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Identification of PSMD14 as a potential novel prognosis biomarker and therapeutic target for osteosarcoma.
    Gong Y; Wei ZR
    Cancer Rep (Hoboken); 2022 Jul; 5(7):e1522. PubMed ID: 34383385
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Identification of the Novel Target Genes for Osteosarcoma Therapy Based on Comprehensive Bioinformatic Analysis.
    Zhou X; Fan Y; Ye W; Jia B; Yang Y; Liu Y
    DNA Cell Biol; 2020 Jul; 39(7):1172-1180. PubMed ID: 32584170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.